The definition of "R1" lymph node dissection status in patients undergoing curative-aim gastrectomy for gastric carcinoma: A proof of concept study.

[1]  D. Cunningham,et al.  Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Joon-Oh Park,et al.  A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  A. Strippoli,et al.  A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer , 2020, Journal of surgical oncology.

[4]  G. Darling,et al.  Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancers. , 2020, Journal of gastrointestinal oncology.

[5]  Cheng Xu,et al.  Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy , 2019, Radiation Oncology.

[6]  A. Biondi,et al.  Ratio‐based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: A multicenter retrospective study , 2019, Journal of surgical oncology.

[7]  R. Verhoeven,et al.  Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study , 2019, Gastric Cancer.

[8]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[9]  A. Strippoli,et al.  Preoperative therapy and long-term survival in gastric cancer: One size does not fit all. , 2018, Surgical oncology.

[10]  Zhen Zhang,et al.  Adjuvant chemoradiotherapy versus adjuvant chemotherapy for R1 resected gastric cancer: a retrospective cohort study. , 2018, The British journal of radiology.

[11]  H. Putter,et al.  Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. , 2018, The Lancet. Oncology.

[12]  J. Ajani,et al.  Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy , 2018, Journal of Gastrointestinal Surgery.

[13]  Zhen-ning Wang,et al.  Anatomical location of metastatic lymph nodes: an indispensable prognostic factor for gastric cancer patients who underwent curative resection , 2018, Scandinavian journal of gastroenterology.

[14]  J. Yun,et al.  Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer , 2017, Journal of Cancer.

[15]  Ping Li,et al.  Differences in the multimodal treatment of gastric cancer: East versus west , 2017, Journal of surgical oncology.

[16]  A. Biondi,et al.  Surgical anatomy of gastric lymphatic drainage. , 2017, Translational gastroenterology and hepatology.

[17]  M. Feith,et al.  What to do after R1‐resection of adenocarcinomas of the esophagogastric junction? , 2016, Journal of surgical oncology.

[18]  Yoon Young Choi,et al.  A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems , 2016, PloS one.

[19]  D. Shin,et al.  Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. , 2014, The Lancet. Oncology.

[20]  He Yulong,et al.  A New pN Staging System Based on Both the Number and Anatomic Location of Metastatic Lymph Nodes in Gastric Cancer , 2014, Journal of Gastrointestinal Surgery.

[21]  M. Verheij,et al.  Oesophagogastric cancer: exploring the way to an individual approach , 2015 .

[22]  S. Choi,et al.  Anatomic Extent of Metastatic Lymph Nodes: Still Important for Gastric Cancer Prognosis , 2014, Annals of Surgical Oncology.

[23]  L. Helyer,et al.  Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival , 2012, Gastric Cancer.

[24]  Joon-Oh Park,et al.  Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  H. Putter,et al.  Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Zhen-ning Wang,et al.  Prognostic Significance of Microscopic Positive Margins for Gastric Cancer Patients with Potentially Curative Resection , 2009, Annals of Surgical Oncology.

[27]  A. Nashimoto,et al.  D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. , 2008, The New England journal of medicine.

[28]  J. Cheong,et al.  Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15‐year experience at a single institute , 2007, Journal of surgical oncology.

[29]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[30]  Scott A. Hundahl,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2001, The New England journal of medicine.

[31]  C. Velde,et al.  Computer analysis in making preoperative decisions: A rational approach to lymph node dissection in gastric cancer patients , 1989, The British journal of surgery.

[32]  Japanese Gastric Cancer Association.  Japanese Classification of Gastric Carcinoma – 2nd English Edition – , 1998, Gastric Cancer.